Option Care Health (OPCH) director receives $200,000 restricted stock grant

Rhea-AI Filing Summary

Pate R Carter reported acquisition or exercise transactions in this Form 4 filing.

Option Care Health, Inc. director Pate R. Carter reported receiving an equity grant in the form of restricted stock units. The award covers 8,997 shares of common stock at a stated price of $0.00 per share and brings direct holdings to 20,620 shares after the transaction. A footnote explains the restricted stock units were valued at $200,000 based on the closing price on May 20, 2026, and they vest in full on May 20, 2027.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Pate R Carter

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	8,997	$0.00	--

Holdings After Transaction: Common Stock — 20,620 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSU grant size: 8,997 shares Grant value: $200,000 Price per share in table: $0.00 per share +2 more

5 metrics

RSU grant size 8,997 shares Restricted stock units granted on May 20, 2026

Grant value $200,000 Value of RSU grant based on May 20, 2026 closing price

Price per share in table $0.00 per share Form 4 transaction price for the RSU grant

Shares held after transaction 20,620 shares Direct holdings following the award

Vesting date May 20, 2027 RSUs vest in full on this date

Key Terms

restricted stock units, vest in full, closing price, Grant, award, or other acquisition

4 terms

restricted stock units financial

"The reporting person received an award of restricted stock units on May 20, 2026, which vest in full on May 20, 2027."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

vest in full financial

"restricted stock units on May 20, 2026, which vest in full on May 20, 2027."

closing price financial

"calculated to reflect $200,000 of value based on the closing price of the issuer's common stock on May 20, 2026."

Grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pate R Carter

(Last) (First) (Middle)

C/O OPTION CARE HEALTH, INC.

3000 LAKESIDE DRIVE, SUITE 300N

(Street)

BANNOCKBURN ILLINOIS 60015

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Option Care Health, Inc. [ OPCH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/20/2026		A		8,997(1)	A	$0	20,620	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reporting person received an award of restricted stock units on May 20, 2026, which vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect $200,000 of value based on the closing price of the issuer's common stock on May 20, 2026.

	/s/ Michael Bavaro, attorney-in-fact for Mr. Pate	05/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Pate R. Carter report in this Option Care Health (OPCH) Form 4?

Pate R. Carter reported receiving a grant of restricted stock units representing 8,997 shares of Option Care Health common stock. The award is a compensation-related acquisition, not an open-market purchase, and was priced at $0.00 per share in the filing’s transaction table.

How large is Pate R. Carter’s new equity award in OPCH shares?

The new equity award covers 8,997 restricted stock units tied to Option Care Health common stock. A footnote states the number of units was set to reflect $200,000 of value, using the issuer’s closing stock price on May 20, 2026, to calculate the grant size.

When do Pate R. Carter’s Option Care Health restricted stock units vest?

The restricted stock units granted to Pate R. Carter vest in full on May 20, 2027. Until that date, the units typically remain subject to vesting conditions; once vested, they can generally convert into shares of common stock according to the award’s terms.

What are Pate R. Carter’s holdings after this OPCH Form 4 transaction?

After this grant, Pate R. Carter is shown holding 20,620 shares of Option Care Health common stock directly. This figure includes the impact of the 8,997-share restricted stock unit award reported in the filing’s non-derivative transaction table.

Was this OPCH Form 4 transaction a market purchase or sale?

The Form 4 describes the transaction with code “A,” indicating a grant, award, or other acquisition. The filing shows a transaction price of $0.00 per share, signaling a compensation-related equity grant rather than an open-market buy or sell of Option Care Health stock.